135 related articles for article (PubMed ID: 22824539)
1. The significance of 18F-FDG PET/CT in secondary hemophagocytic lymphohistiocytosis.
Zhang LJ; Xu J; Liu P; Ding CY; Li JY; Qiu HX; Zhang SJ
J Hematol Oncol; 2012 Jul; 5():40. PubMed ID: 22824539
[TBL] [Abstract][Full Text] [Related]
2. The significance of pre-therapeutic F-18-FDG PET-CT in lymphoma-associated hemophagocytic lymphohistiocytosis when pathological evidence is unavailable.
Wang J; Wang D; Zhang Q; Duan L; Tian T; Zhang X; Li J; Qiu H
J Cancer Res Clin Oncol; 2016 Apr; 142(4):859-71. PubMed ID: 26666755
[TBL] [Abstract][Full Text] [Related]
3.
Wei A; Lu X; Ma H; Lian H; Yang X; Zhang L; Wang D; Chen S; Zhang Q; Li Z; Zhang R; Yang J; Wang T
Contrast Media Mol Imaging; 2022; 2022():4849081. PubMed ID: 35510179
[TBL] [Abstract][Full Text] [Related]
4. 18F-FDG PET/CT for identifying the potential causes and extent of secondary hemophagocytic lymphohistiocytosis.
Yuan L; Kan Y; Meeks JK; Ma D; Yang J
Diagn Interv Radiol; 2016; 22(5):471-5. PubMed ID: 27537853
[TBL] [Abstract][Full Text] [Related]
5. Clinical Value of
Liang J; Cao H; Wu B; Liu Y; He Y; Xu B; Sun Y; Ye B; Lin J
Front Immunol; 2021; 12():745211. PubMed ID: 34867971
[TBL] [Abstract][Full Text] [Related]
6. The role of
Zheng Y; Hu G; Liu Y; Ma Y; Dang Y; Li F; Xing H; Wang T; Huo L
Clin Radiol; 2016 Dec; 71(12):1248-1254. PubMed ID: 27387105
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of 18F-fluorodeoxyglucose positron emission tomography/computed tomography at delayed phase for diagnosis and prognosis of malignant pleural mesothelioma.
Abe Y; Tamura K; Sakata I; Ishida J; Ozeki Y; Tamura A; Uematsu K; Sakai H; Goya T; Kanazawa M; Machida K
Oncol Rep; 2012 Feb; 27(2):333-8. PubMed ID: 22024889
[TBL] [Abstract][Full Text] [Related]
8. [The clinical value of F-18 FDG PET/CT in patients with secondary hemophagocytic syndrome].
Wang XB; Zhu YX; Liu X; Pan B; Zhang L; Han YS; Cai XY; Zhu WB; Wu JS; Sun ZM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1698-701. PubMed ID: 25543499
[TBL] [Abstract][Full Text] [Related]
9. Clinical implication of F-18 FDG PET/CT in patients with secondary hemophagocytic lymphohistiocytosis.
Kim J; Yoo SW; Kang SR; Bom HS; Song HC; Min JJ
Ann Hematol; 2014 Apr; 93(4):661-7. PubMed ID: 24061788
[TBL] [Abstract][Full Text] [Related]
10. Prospective comparison of combined 18F-FDG and 18F-NaF PET/CT vs. 18F-FDG PET/CT imaging for detection of malignancy.
Lin FI; Rao JE; Mittra ES; Nallapareddy K; Chengapa A; Dick DW; Gambhir SS; Iagaru A
Eur J Nucl Med Mol Imaging; 2012 Feb; 39(2):262-70. PubMed ID: 22065013
[TBL] [Abstract][Full Text] [Related]
11. Utility of FDG-PET/CT in the diagnosis of IgG4-related diseases.
Zhao Z; Wang Y; Guan Z; Jin J; Huang F; Zhu J
Clin Exp Rheumatol; 2016; 34(1):119-25. PubMed ID: 26842851
[TBL] [Abstract][Full Text] [Related]
12. Muscle Involvement Caused by Chronic Active Epstein-Barr Virus Infection on 18F-FDG PET/CT in a Pediatric Patient.
Yang X; Lu X; Kan Y; Wang W; Yang J
Clin Nucl Med; 2022 Mar; 47(3):268-270. PubMed ID: 34524166
[TBL] [Abstract][Full Text] [Related]
13. Preoperative characterization of indeterminate large adrenal masses with dual tracer PET-CT using fluorine-18 fluorodeoxyglucose and gallium-68-DOTANOC: initial results.
Naswa N; Sharma P; Soundararajan R; Patnecha M; Lata S; Kumar R; Malhotra A; Bal C
Diagn Interv Radiol; 2013; 19(4):294-8. PubMed ID: 23439252
[TBL] [Abstract][Full Text] [Related]
14. Atypical Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis simulating lymphadenitis on
Lu J; Fang Q; Ma C; Su F; Chen G; Huang M; Wang W; Su X
Hell J Nucl Med; 2017; 20(3):254-257. PubMed ID: 29177266
[TBL] [Abstract][Full Text] [Related]
15. Localization and prediction of malignant potential in recurrent pheochromocytoma/paraganglioma (PCC/PGL) using 18F-FDG PET/CT.
Fikri AS; Kroiss A; Ahmad AZ; Zanariah H; Lau WF; Uprimny C; Donnemiller E; Kendler D; Nordin AJ; Virgolini IJ
Acta Radiol; 2014 Jun; 55(5):631-40. PubMed ID: 24037430
[TBL] [Abstract][Full Text] [Related]
16. SUVmax of 18F-FDG PET/CT in the differential diagnosis of benign and malignant thyroid nodules according to tumor volume.
Kim TH; Ji YB; Song CM; Kim JY; Choi YY; Park JS; Tae K
World J Surg Oncol; 2015 Jul; 13():217. PubMed ID: 26179774
[TBL] [Abstract][Full Text] [Related]
17. Exploring spatial overlap of high-uptake regions derived from dual tracer positron emission tomography-computer tomography imaging using 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine in nonsmall cell lung cancer patients: a prospective pilot study.
Liu J; Li C; Hu M; Lu J; Shi X; Xing L; Sun X; Fu Z; Yu J; Meng X
Medicine (Baltimore); 2015 May; 94(17):e678. PubMed ID: 25929896
[TBL] [Abstract][Full Text] [Related]
18. Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer.
Miccò M; Vargas HA; Burger IA; Kollmeier MA; Goldman DA; Park KJ; Abu-Rustum NR; Hricak H; Sala E
Eur J Radiol; 2014 Jul; 83(7):1169-1176. PubMed ID: 24767630
[TBL] [Abstract][Full Text] [Related]
19. Prognosis predicting value of semiquantitative parameters of visceral adipose tissue and subcutaneous adipose tissue of
Liu J; Yang X; Yang J
Ann Nucl Med; 2021 Mar; 35(3):386-396. PubMed ID: 33469854
[TBL] [Abstract][Full Text] [Related]
20. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]